Đang chuẩn bị liên kết để tải về tài liệu:
Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer

Ovarian cancer remains the most fatal gynecological malignancy. Current therapeutic options are limited due to late diagnosis in the majority of the cases, metastatic spread to the peritoneal cavity and the onset of chemo-resistance. | Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer